Search research articles
Contact Us
Filters
Showing results (131-140 of 208) with videos related to
Page
of 21
Sort By:
The American Journal of Medicine
|
June 1, 1988
Amelioration of vincristine neurotoxicity by glutamic acid
D V Jackson, H B Wells, J N Atkins, et al.
Cancer Treatment Reports
|
February 1, 1987
Phase II trial of high-dose cytarabine and cisplatin in locoregional previously untreated squamous carcinoma of the head and neck: a Piedmont Oncology Association Study
J B Craig, B L Powell, D V Jackson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 1, 2012
Phase II study of induction cisplatin and irinotecan followed by concurrent carboplatin, etoposide, and thoracic radiotherapy for limited-stage small-cell lung cancer, CALGB 30206
Michael J Kelley, Jeffrey A Bogart, Lydia D Hodgson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 3, 2002
Assessment of quality of life and oral function of patients participating in a phase II study of radioprotection of oral and pharyngeal mucosa by the prostaglandin E(1) analog misoprostol (RTOG 96-07)
Darlene J Johnson, Charles B Scott, James E Marks, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 8, 2000
Paclitaxel/ifosfamide or navelbine/ifosfamide chemotherapy for advanced non-small cell lung cancer: CALGB 9532
M C Perry, D C Ihde, J E Herndon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 5, 2007
Gemcitabine and irinotecan for patients with untreated extensive stage small cell lung cancer: SWOG 0119
Wallace Akerley, Jason McCoy, Paul J Hesketh, et al.
Clinical Lung Cancer
|
April 23, 2005
Split-course versus continuous thoracic radiation therapy for limited-stage small-cell lung cancer: final report of a randomized phase III trial
A William Blackstock, Jeffery A Bogart, Charles Matthews, et al.
American Journal of Clinical Oncology
|
December 1, 1991
High-dose 24-hour infusion of 5-fluorouracil in metastatic prostate cancer. A phase II trial of the Piedmont Oncology Association
J N Atkins, H B Muss, D Case, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 16, 2005
Prevalence of complementary and alternative medicine use in cancer patients during treatment
Jennifer S Yates, Karen M Mustian, Gary R Morrow, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 12, 2005
Does an oral analgesic protocol improve pain control for patients with cancer? An intergroup study coordinated by the Eastern Cooperative Oncology Group
C S Cleeland, R K Portenoy, M Rue, et al.
Page
of 21
Search research articles
Search
Showing results (131-140 of 208) with videos related to
Sort By:
Page
of 21
The American Journal of Medicine
|
June 1, 1988
Amelioration of vincristine neurotoxicity by glutamic acid
D V Jackson, H B Wells, J N Atkins, et al.
Cancer Treatment Reports
|
February 1, 1987
Phase II trial of high-dose cytarabine and cisplatin in locoregional previously untreated squamous carcinoma of the head and neck: a Piedmont Oncology Association Study
J B Craig, B L Powell, D V Jackson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 1, 2012
Phase II study of induction cisplatin and irinotecan followed by concurrent carboplatin, etoposide, and thoracic radiotherapy for limited-stage small-cell lung cancer, CALGB 30206
Michael J Kelley, Jeffrey A Bogart, Lydia D Hodgson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 3, 2002
Assessment of quality of life and oral function of patients participating in a phase II study of radioprotection of oral and pharyngeal mucosa by the prostaglandin E(1) analog misoprostol (RTOG 96-07)
Darlene J Johnson, Charles B Scott, James E Marks, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 8, 2000
Paclitaxel/ifosfamide or navelbine/ifosfamide chemotherapy for advanced non-small cell lung cancer: CALGB 9532
M C Perry, D C Ihde, J E Herndon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 5, 2007
Gemcitabine and irinotecan for patients with untreated extensive stage small cell lung cancer: SWOG 0119
Wallace Akerley, Jason McCoy, Paul J Hesketh, et al.
Clinical Lung Cancer
|
April 23, 2005
Split-course versus continuous thoracic radiation therapy for limited-stage small-cell lung cancer: final report of a randomized phase III trial
A William Blackstock, Jeffery A Bogart, Charles Matthews, et al.
American Journal of Clinical Oncology
|
December 1, 1991
High-dose 24-hour infusion of 5-fluorouracil in metastatic prostate cancer. A phase II trial of the Piedmont Oncology Association
J N Atkins, H B Muss, D Case, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 16, 2005
Prevalence of complementary and alternative medicine use in cancer patients during treatment
Jennifer S Yates, Karen M Mustian, Gary R Morrow, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 12, 2005
Does an oral analgesic protocol improve pain control for patients with cancer? An intergroup study coordinated by the Eastern Cooperative Oncology Group
C S Cleeland, R K Portenoy, M Rue, et al.
Page
of 21